In line with this, the ROCK2-selective inhibitor TDI01 showed a trend toward reducing liver fibrosis in five of six patients in an extended clinical study ( ChiCTR2400082056 ) ( 23 ) ( Figure 1 ).
1
—
—
In line with this, the ROCK2-selective inhibitor TDI01 showed a trend toward reducing liver fibrosis in five of six patients in an extended clinical study ( ChiCTR2400082056 ) ( 23 ) ( Figure 1 ).